Coronary Heart Disease: Effective Use of Patent Chinese Medicines for Different Stages

Patent Chinese medicines are widely used in the treatment of coronary heart disease due to their convenience and efficacy. During an acute angina attack, it is recommended that patients use fast-acting medications such as Suxiao Jiuxin Pills or Compound Danshen Dropping Pills. These formulations can quickly alleviate symptoms and provide immediate relief during episodes of chest pain.

Choosing the Right Medication Based on Syndrome Patterns

In the remission phase of coronary heart disease, treatment should be tailored according to the patient's specific TCM (Traditional Chinese Medicine) syndrome pattern. For patients with qi deficiency, characterized by fatigue and shortness of breath, tonifying medicines like Qishen Yiqi Dropping Pills or Buzhong Yiqi Granules are commonly prescribed to replenish vital energy and support cardiovascular function.

Managing Blood Stasis and Chest Obstruction

For individuals with blood stasis syndrome, which often presents with severe and fixed chest pain, blood-activating and stasis-resolving medications such as Naoxintong Capsules are preferred. These help improve circulation and reduce the frequency and intensity of angina episodes.

Patients experiencing phlegm obstruction, often marked by a feeling of tightness and oppression in the chest, may benefit from medications like Musk Cardiotonic Pills, Compound Danshen Dropping Pills, or Suxiao Jiuxin Pills. These formulas help resolve phlegm, unblock the meridians, and restore normal chest comfort.

Addressing Cold Aggregation and Yang Deficiency

For those who experience angina triggered by cold exposure and exhibit symptoms of cold intolerance, warming formulas such as Fuzi LIZhong Pills are recommended. These medicines help to restore yang energy and dispel internal cold, thereby preventing cold-induced cardiac episodes.

In conclusion, the treatment of coronary heart disease with patent Chinese medicines requires a stage-specific and syndrome-differentiated approach. Whether in the acute or remission phase, selecting the appropriate formulation can significantly improve outcomes and enhance quality of life for patients.